1. Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
- Author
-
Richard S. Houlston, Subhayan Chattopadhyay, Hauke Thomsen, Jan Sundquist, Kari Hemminki, Amit Sud, and Kristina Sundquist
- Subjects
Male ,0301 basic medicine ,Myeloid ,Databases, Factual ,Immunology ,Biochemistry ,03 medical and health sciences ,0302 clinical medicine ,Polycythemia vera ,Risk Factors ,hemic and lymphatic diseases ,medicine ,Humans ,Genetic Predisposition to Disease ,Registries ,Letter to Blood ,Myelofibrosis ,Sweden ,business.industry ,Essential thrombocythemia ,Myelodysplastic syndromes ,Cancer ,Myeloid leukemia ,Cell Biology ,Hematology ,medicine.disease ,Leukemia, Myeloid, Acute ,Leukemia ,030104 developmental biology ,medicine.anatomical_structure ,Hematologic Neoplasms ,Myelodysplastic Syndromes ,030220 oncology & carcinogenesis ,Cancer research ,Female ,business - Abstract
TO THE EDITOR: Myeloid malignancies are clonal proliferative diseases with shared but diverse phenotype characteristics; this classification includes (1) the myeloproliferative neoplasms (MPNs), polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF); (2) chronic myeloid
- Published
- 2018